Biogen

Alzheimer's & Dementia

FDA approves at-home Alzheimer's shot to effectively slow disease

The FDA has approved a new version of an Alzheimer’s disease drug that can be given as a quick at-home weekly injection, offering patients a more convenient option than lengthy infusion-center visits. It will be widely available from October 6, 2025.
Alzheimer's & Dementia

Another big Alzheimer’s drug fails in late-stage human trials

A shockwave hit the Alzheimer’s research community today after Biogen announced it was discontinuing two massive final phase human trials into the promising Alzheimer’s drug aducanumab. The announcement is the latest in a long line of failed Alzheimer’s drugs targeting the amyloid hypothesis.